![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-desktop-w27gif-57924.gif)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-mobile-w27gif-62411.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.fiercepharma.com/pharma/vertex-clinches-trikafta-and-other-cystic-fibrosis-drug-reimbursement-deal-england
https://www.fiercepharma.com/pharma/vertex-presents-longer-term-data-shows-durability-and-consistency-casgevy
https://endpts.com/tessera-unveils-promising-in-vivo-gene-editing-treatment-for-sickle-cell-in-an-increasingly-competitive-field-asgct24/
https://www.fiercepharma.com/pharma/gene-therapy-war-bluebird-trails-vertex-patient-starts-leads-treatment-centers
https://www.reuters.com/business/healthcare-pharmaceuticals/vertex-tops-q1-profit-estimates-robust-demand-cystic-fibrosis-treatments-2024-05-06/
https://endpts.com/vertex-touts-casgevy-sickle-cell-launch-as-bluebird-makes-progress-with-rival-lyfgenia/